Notably, one adenosarcoma displayed a MED12 mutation, but the latter was not in exon 2, the exon recurrently affected in PTs (Cani et al., 2015; Piscuoglio et al., 2016b; Tan et al., 2015). The gene discussed is MED12; the disease is adenosarcoma.